These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10933368)

  • 21. Outcomes following surgical ventricular restoration for patients with clinically advanced congestive heart failure (New York Heart Association Class IV).
    Williams JA; Weiss ES; Patel ND; Nwakanma LU; Conte JV
    J Card Fail; 2007 Aug; 13(6):431-6. PubMed ID: 17675056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program.
    Olsson LG; Swedberg K; Ducharme A; Granger CB; Michelson EL; McMurray JJ; Puu M; Yusuf S; Pfeffer MA;
    J Am Coll Cardiol; 2006 May; 47(10):1997-2004. PubMed ID: 16697316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal function, neurohormonal activation, and survival in patients with chronic heart failure.
    Hillege HL; Girbes AR; de Kam PJ; Boomsma F; de Zeeuw D; Charlesworth A; Hampton JR; van Veldhuisen DJ
    Circulation; 2000 Jul; 102(2):203-10. PubMed ID: 10889132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of long-term survival in patients with malignant ventricular arrhythmias.
    Gomes JA; Mehta D; Ip J; Winters SL; Camunas J; Ergin A; Newhouse TT; Pe E
    Am J Cardiol; 1997 Apr; 79(8):1054-60. PubMed ID: 9114763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort.
    Vasan RS; Larson MG; Benjamin EJ; Evans JC; Reiss CK; Levy D
    J Am Coll Cardiol; 1999 Jun; 33(7):1948-55. PubMed ID: 10362198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study.
    Stampfer MJ; Colditz GA; Willett WC; Manson JE; Rosner B; Speizer FE; Hennekens CH
    N Engl J Med; 1991 Sep; 325(11):756-62. PubMed ID: 1870648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical characteristics of vesnarinone.
    Feldman AM
    Drug Saf; 2004; 27 Suppl 1():1-9. PubMed ID: 15293848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of hormone therapy on mortality rates among women with heart failure and coronary artery disease.
    Bibbins-Domingo K; Lin F; Vittinghoff E; Barrett-Connor E; Hulley SB; Grady D; Shlipak MG
    Am J Cardiol; 2005 Jan; 95(2):289-91. PubMed ID: 15642574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Precautions for use and adverse effects of vesnarinone: potential mechanisms and future therapies.
    Bertolet BD
    Drug Saf; 2004; 27 Suppl 1():11-8. PubMed ID: 15293849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relation of circulating cardiac myosin light chain 1 isoform in stable severe congestive heart failure to survival and treatment with flosequinan.
    Hansen MS; Stanton EB; Gawad Y; Packer M; Pitt B; Swedberg K; Rouleau JL;
    Am J Cardiol; 2002 Nov; 90(9):969-73. PubMed ID: 12398964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Trends in pharmacological treatment of congestive heart failure].
    Halawa B
    Pol Merkur Lekarski; 1999 Mar; 6(33):152-6. PubMed ID: 10365602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mortality and readmission of hospitalized patients with congestive heart failure and preserved versus depressed systolic function.
    Tsutsui H; Tsuchihashi M; Takeshita A
    Am J Cardiol; 2001 Sep; 88(5):530-3. PubMed ID: 11524063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is there a role for positive inotropic agents in congestive heart failure: focus on mortality.
    Amidon TM; Parmley WW
    Clin Cardiol; 1994 Dec; 17(12):641-7. PubMed ID: 7867235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure. CHF-STAT Investigators.
    Massie BM; Fisher SG; Radford M; Deedwania PC; Singh BN; Fletcher RD; Singh SN
    Circulation; 1996 Jun; 93(12):2128-34. PubMed ID: 8925581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of elderly patients with congestive heart failure--design of the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF).
    Brunner-La Rocca HP; Buser PT; Schindler R; Bernheim A; Rickenbacher P; Pfisterer M;
    Am Heart J; 2006 May; 151(5):949-55. PubMed ID: 16644310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulse pressure and cardiovascular events in postmenopausal women with coronary heart disease.
    Nair GV; Chaput LA; Vittinghoff E; Herrington DM;
    Chest; 2005 May; 127(5):1498-506. PubMed ID: 15888820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.
    Bardy GH; Lee KL; Mark DB; Poole JE; Packer DL; Boineau R; Domanski M; Troutman C; Anderson J; Johnson G; McNulty SE; Clapp-Channing N; Davidson-Ray LD; Fraulo ES; Fishbein DP; Luceri RM; Ip JH;
    N Engl J Med; 2005 Jan; 352(3):225-37. PubMed ID: 15659722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Digitalis for treatment of congestive heart failure in patients in sinus rhythm.
    Hood WB; Dans AL; Guyatt GH; Jaeschke R; McMurray JJ
    Cochrane Database Syst Rev; 2004; (2):CD002901. PubMed ID: 15106182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose dependence of chronic positive inotropic effect of vesnarinone in patients with congestive heart failure due to idiopathic or ischemic cardiomyopathy.
    Kass DA; Van Anden E; Becker LC; Kasper EK; White WB; Feldman AM
    Am J Cardiol; 1996 Sep; 78(6):652-6. PubMed ID: 8831399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heart rate is a marker of amiodarone mortality reduction in severe heart failure. The GESICA-GEMA Investigators. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina-Grupo de Estudios Multicéntricos en Argentina.
    Nul DR; Doval HC; Grancelli HO; Varini SD; Soifer S; Perrone SV; Prieto N; Scapin O
    J Am Coll Cardiol; 1997 May; 29(6):1199-205. PubMed ID: 9137213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.